<DOC>
	<DOCNO>NCT01529242</DOCNO>
	<brief_summary>The purpose study evaluate non-inferiority clinical efficacy two different drug association treatment acute cutaneous rash child 2 12 year old .</brief_summary>
	<brief_title>Comparison Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone Cutaneous Rash Treatment</brief_title>
	<detailed_description>- double-blind , non-inferiority , prospective , parallel group trial . - Experiment duration : 05 day . - 03 visit ( day 0 , 48 hour day 5 ) . - Efficacy evaluate acute cutaneous rash base symptom score - Adverse event evaluation .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<mesh_term>Dexchlorpheniramine</mesh_term>
	<mesh_term>Chlorpheniramine</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Consent patient legal guardian ; Clinical diagnosis acute cutaneous rash define presence erythematous papule healthy skin , different size , itchy fleet Children age 2 11 year 11 month ( 30 kg ) ; Participation clinical trial 30 day prior study entry ; Patients history hypersensitivity desloratadine prednisolone corticosteroid use contraindication ; Patients clinically significant disease cutaneous rash include hematopoietic , cardiovascular , renal , neurological , psychiatric autoimmune disorder ; Patients treatment monoamine oxidase inhibitor ( MAOIs ) ; Patients diagnose dermatosis</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>